Results 221 to 230 of about 40,023 (293)

Online screening for excessive daytime sleepiness: a feasibility study. [PDF]

Front Psychol
Hlodak J, Geckova AM, Carnakovic S, Feketeova E.   +3 more
europepmc   +1 more source

Facial Emotion Recognition in Children With Narcolepsy Type 1

Journal of Sleep Research, Volume 35, Issue 2, April 2026.
ABSTRACT Narcolepsy type 1 is a neurological disorder typically emerging in childhood or adolescence, characterised by excessive daytime sleepiness, cataplexy and rapid eye movement sleep‐related symptoms. Beyond its core features, increasing evidence suggests an impact on socio‐cognitive development, including difficulties in understanding others ...
Marco Veneruso, Paola Del Sette, Ramona Cordani, Antonella Barbieri, Lorenzo Chiarella, Serena Lecce, Cristina Venturino, Salvatore Lo Cascio, Francesco Biscarini, Fabio Pizza, Lino Nobili, Giuseppe Plazzi   +11 more
wiley   +1 more source

The Hourly Apnea-Hypopnea Duration Better Correlates with OSA-Related Nocturnal Hypoxemia and Excessive Daytime Sleepiness Rather Than AHI. [PDF]

Nat Sci Sleep
Wang Y, Yue W, Zhou B, Zhang J, He Y, Wang M, Hu K.   +6 more
europepmc   +1 more source

The Effect of Deep Brain Stimulation on Sleep and Cognition in Patients With Parkinson's Disease

Journal of Sleep Research, Volume 35, Issue 2, April 2026.
ABSTRACT Sleep–wake disturbances and cognitive decline are among the most common nonmotor symptoms of Parkinson's disease (PD). Deep brain stimulation (DBS) can successfully alleviate motor symptoms. However, the impact on sleep–wake disturbances and cognitive decline, and their interaction, is yet unclear.
Monique E. H. Valk‐Geuke, Gert J. Geurtsen, Rob M. A. de Bie, Rick Schuurman, Martijn Beudel, Esmée Verwijk   +5 more
wiley   +1 more source

0153 Extreme Morning Chronotypes Are Often Familial And Not Exceedingly Rare: The Estimated Prevalence Of Familial Advanced Sleep Phase (FASP) In A Sleep Clinic Population [PDF]

, 2019
Ashbrook, Liza H, Curtis, Brian J, Finn, Laurel, Fu, Ying-Hui, Jones, Chris R, Ptacek, Louis J, Young, Terry B   +6 more
core   +2 more sources

Excessive daytime sleepiness in myotonic dystrophy: a narrative review. [PDF]

Front Neurol
Hoxhaj D, Pascazio A, Maestri M, Ricci G, Fabbrini M, Torresi FB, Siciliano G, Bonanni E.   +7 more
europepmc   +1 more source

Sleep and Trajectories of Respiratory and Allergic Symptoms Between 1 and 5.5 Years of Age in the Elfe Birth Cohort

Journal of Sleep Research, Volume 35, Issue 2, April 2026.
ABSTRACT Sleep troubles and respiratory and allergic health issues are associated in children, but the timeline of their association is overlooked. This study investigates the associations between sleep patterns at age 1 and respiratory and allergic multi‐trajectories (RespA‐MTG) between ages 1 and 5.5, and the associations between these multi ...
Daniele Saade, Rosalie Delvert, Chantal Raherison‐Semjen, Orianne Dumas, Mohammed Sedki, Marie‐Noëlle Dufourg, Blandine de Lauzon‐Guillain, Bénédicte Leynaert, Rachel Nadif, Annabelle Bédard, Sabine Plancoulaine   +10 more
wiley   +1 more source

Hypoxic Burden in Children With Sleep‐Disordered Breathing: Determinants and Correlates

Journal of Sleep Research, Volume 35, Issue 2, April 2026.
ABSTRACT Hypoxic burden (HB) is an emerging metric for quantifying intermittent hypoxia associated with sleep apnea, offering potential advantages over traditional measures such as the apnea‐hypopnea index (AHI). This study evaluated the distribution and clinical significance of non‐respiratory event‐specific HB in children and adolescents with ...
Plamen Bokov, Benjamin Dudoignon, Christophe Delclaux   +2 more
wiley   +1 more source

The Burden of Sleep/Wake Disorders: Excessive Daytime Sleepiness and Insomnia Project. [PDF]

Methods Protoc
Tüzün M, Kallweit U, Seidel S, Endrich O, Trelle S, Leone MA, Bruni O, Dodel R, Konti M, Lolich M, Pupillo E, Ramankulov D, Vignatelli L, Meyer-Massetti C, Schmidt M, Bassetti CLA.   +15 more
europepmc   +1 more source

Targeting Expanded CUG and CTG Repeats as a Therapeutic Approach for Myotonic Dystrophy Type 1 (DM1)

ChemMedChem, Volume 21, Issue 5, 13 March 2026.
DM1 is an RNA gain‐of‐function disease caused by CTG repeat expansion, producing toxic r(CUG)exp RNA that sequesters MBNL1 and impairs splicing. This review covers the field of CUG and CTG ligands identified or rationally designed as DM1 drug candidates, highlighting their molecular design, RNA‐ or DNA‐binding modes, in vitro affinities and ...
Camille Richagneux, Anton Granzhan
wiley   +1 more source